How to overcome resistance to immune checkpoint inhibitors in colorectal cancer: From mechanisms to translation.

Wang, Qianyu; Shen, Xiaofei; Chen, Gang; Du, Junfeng

Wang, Qianyu; Shen, Xiaofei; Chen, Gang; Du, Junfeng.

Afiliação

Wang Q; Medical Department of General Surgery, The 1st Medical Center, Chinese PLA General Hospital, Beijing, China.
Shen X; The Second School of Clinical Medicine, Shanxi Medical University, Taiyuan, China.
Chen G; Department of General Surgery, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Du J; Medical Department of General Surgery, The 1st Medical Center, Chinese PLA General Hospital, Beijing, China.

Int J Cancer ; 153(4): 709-722, 2023 08 15.

Article em En | MEDLINE | ID: mdl-36752642

Assuntos

Neoplasias Colorretais; Inibidores de Checkpoint Imunológico; Humanos; Inibidores de Checkpoint Imunológico/farmacologia; Inibidores de Checkpoint Imunológico/uso terapêutico; Reparo de Erro de Pareamento de DNA; Imunoterapia; Neoplasias Colorretais/tratamento farmacológico; Neoplasias Colorretais/genética; Neoplasias Colorretais/patologia; Instabilidade de Microssatélites

Palavras-chave

colorectal cancer; drug resistance; immune checkpoint inhibitors; mechanism; treatment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Inibidores de Checkpoint Imunológico Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google